Holdings

Trails Edge Capital Partners, LP

As of Sep 30, 2026, Trails Edge Capital Partners, LP reported 36 positions worth US$666M. Largest: LB Pharmaceuticals Inc, BioMarin Pharmaceutical Inc. and Nurix Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
LB Pharmaceuticals Inc1.15MUS$44.1M−374KSep 30, 2026
BioMarin Pharmaceutical Inc.667KUS$40M+155KSep 30, 2026
Nurix Therapeutics, Inc.1.57MUS$37.3Mno changeSep 30, 2026
Obsidian Therapeutics, Inc.2.5MUS$34.3MnewSep 30, 2026
Immunocore Holdings plc1.06MUS$32.2MnewSep 30, 2026
4D Molecular Therapeutics, Inc.2.23MUS$31.9Mno changeSep 30, 2026
Design Therapeutics, Inc.2.5MUS$31.4M+499KSep 30, 2026
Cytokinetics, Incorporated470KUS$31M+182KSep 30, 2026
First Tracks Biotherapeutics, Inc.814KUS$28.8M−700KSep 30, 2026
Sensei Biotherapeutics, Inc.942KUS$28M+426KSep 30, 2026